Strasbourg, France

Gilbert Marciniak

This inventor holds 2 USPTO granted patents. Top assignee: Merrell Dow Pharmaceuticals. Active years: 1992-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilbert Marciniak. Retrieved from https://idiyas.com/inventor/gilbert-marciniak-w9layhpa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 1992-1993

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gilbert Marciniak: Innovator in Ascorbic Acid Derivatives

Introduction

Gilbert Marciniak is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of chemistry, particularly in the development of ascorbic acid derivatives. With a total of two patents to his name, Marciniak's work focuses on compounds that exhibit cellular protective properties.

Latest Patents

Marciniak's latest patents involve derivatives of 3,4-dihydroxy-2,5-dihydrofuran-5-ones. These patents disclose intermediates and processes useful for the preparation of these compounds. The compounds are recognized for their utility as free-radical scavengers, which are essential in protecting cells from oxidative stress.

Career Highlights

Gilbert Marciniak is associated with Merrell Dow Pharmaceuticals, where he applies his expertise in chemistry to advance pharmaceutical innovations. His work has contributed to the understanding and application of ascorbic acid derivatives in various health-related fields.

Collaborations

Marciniak collaborates with J Martin Grisar, enhancing the research and development efforts in their projects. Their partnership exemplifies the importance of teamwork in scientific advancements.

Conclusion

Gilbert Marciniak's contributions to the field of chemistry, particularly through his patents on ascorbic acid derivatives, highlight his role as an innovator. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…